Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control

Number of the records: 1

Title	Sulfonylurea vs insulin therapy in individuals with sulfonylurea-sensitive permanent neonatal diabetes mellitus, attributable to a KCNJ11 mutation, and poor glycaemic control
Author	Staník Juraj SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV
Co-authors	Dankovcikova A.
	Barák L.
	Škopková Martina SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV
	Palko M.
	Divinec J.
	Klimeš Iwar SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV
	Gašperíková Daniela SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV ^RID ^ORCID

Source document	Diabetic Medicine. Vol. 35, no. 3 (2018), p. 386-391
Language	eng - English
Document kind	rozpis článkov z periodík (rbx)
Citations	MISRA, S. - VEDOVATO, N. - CLIFF, E. - DE FRANCO, E. - HATTERSLEY, A. T. - ASHCROFT, F. M. - OLIVER, N. S. Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. In DIABETIC MEDICINE. ISSN 0742-3071, 2018, vol. 35, no. 9, pp. 1291-1296.
	LETOURNEAU, Lisa R. - GREELEY, Siri Atma W. Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations. In CURRENT DIABETES REPORTS. ISSN 1534-4827, 2019, vol. 19, no. 8, pp.
Category	ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2018
Registered in	WOS
Registered in	SCOPUS
Registered in	CCC
DOI	10.1111/dme.13575

article

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	A

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2018	2017	3.132	Q2	1.628	Q1

Number of the records: 1